- Home
- GBLI vs ZVRA Comparison
GBLI vs ZVRA Comparison
Compare GBLI & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBLI
- ZVRA
- Stock Information
- Founded
- GBLI 2016
- ZVRA 2006
- Country
- GBLI United States
- ZVRA United States
- Employees
- GBLI N/A
- ZVRA N/A
- Industry
- GBLI Property-Casualty Insurers
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- GBLI Finance
- ZVRA Health Care
- Exchange
- GBLI Nasdaq
- ZVRA Nasdaq
- Market Cap
- GBLI 476.1M
- ZVRA 433.5M
- IPO Year
- GBLI 2003
- ZVRA 2015
- Fundamental
- Price
- GBLI $34.80
- ZVRA $7.63
- Analyst Decision
- GBLI
- ZVRA Strong Buy
- Analyst Count
- GBLI 0
- ZVRA 8
- Target Price
- GBLI N/A
- ZVRA $22.29
- AVG Volume (30 Days)
- GBLI 5.4K
- ZVRA 519.4K
- Earning Date
- GBLI 03-11-2025
- ZVRA 03-11-2025
- Dividend Yield
- GBLI 4.08%
- ZVRA N/A
- EPS Growth
- GBLI 70.49
- ZVRA N/A
- EPS
- GBLI 3.12
- ZVRA N/A
- Revenue
- GBLI $441,087,000.00
- ZVRA $23,612,000.00
- Revenue This Year
- GBLI $12.07
- ZVRA $281.10
- Revenue Next Year
- GBLI N/A
- ZVRA $97.98
- P/E Ratio
- GBLI $11.01
- ZVRA N/A
- Revenue Growth
- GBLI N/A
- ZVRA N/A
- 52 Week Low
- GBLI $29.55
- ZVRA $4.20
- 52 Week High
- GBLI $37.00
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- GBLI 44.40
- ZVRA 47.41
- Support Level
- GBLI $34.20
- ZVRA $7.78
- Resistance Level
- GBLI $36.61
- ZVRA $8.33
- Average True Range (ATR)
- GBLI 0.74
- ZVRA 0.40
- MACD
- GBLI -0.16
- ZVRA -0.01
- Stochastic Oscillator
- GBLI 21.43
- ZVRA 45.30
About GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance worldwide. The company's three primary segments are Commercial Specialty, Reinsurance operations, and Exited Lines. The majority of its revenue is from the Commercial Specialty segment. Geographically, the majority is from California.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.